在喀麦隆的宫癌前期治疗结果
Joseph F Nkfusai1, Simon M Manga2,3, Kathleen Nulah2
1Department of Public Health and Hygiene, Faculty of Health Sciences, University of Buea, Cameroon.
International journal of MCH and AIDS
|November 11, 2024
概括
在喀麦隆,宫癌前期的消退性和切除性治疗是有效的,但对于艾滋病毒或大病变的妇女来说效果不那么好. 尽管治疗成功率很高,但治疗后的随访吸收率仍然很低.
科学领域:
- 妇科 妇科 妇科 妇科
- 在瘤学瘤学.
- 公共卫生 公共卫生
背景情况:
- 宫癌前期治疗,如切除和切除,在资源有限的环境中是可以获得和负担得起的.
- 然而,它们的有效性和喀麦隆的治疗后结果仍未得到充分研究.
- 这项研究旨在评估这些程序在喀麦隆妇女的临床结果.
研究的目的:
- 评估喀麦隆子宫癌前期癌症的废除和切除治疗程序的临床结果.
- 确定与治疗有效性和不良影响相关的因素.
- 评估治疗后的随访和怀孕结果的吸收.
主要方法:
- 这是一项涉及170名女性的横截面研究,这些女性在2019年至2020年期间接受了宫癌前期治疗.
- 从程序注册表中抽取数据以获取人口统计,治疗和后续信息.
- 使用后勤回归模型进行统计分析,以确定影响治疗有效性的因素.
主要成果:
- 整体治疗有效率为93.55%,其中94.37%是废除性手术和88.23%是切除性手术.
- 治疗后的随访吸收率为54.71%,尽管意识很高.
- 艾滋病毒阳性女性和高度病变女性的治疗效果较低.
结论:
- 废除和切除治疗在喀麦隆的子宫癌前期有效,副作用最小.
- 艾滋病毒阳性女性和患有较大的病变的女性观察到效率较低.
- 改善治疗后的随访对于管理复发性或持久性宫癌前期癌症至关重要.
更多相关视频
12:14CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells
Published on: June 2, 2022
2.6K
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.0K
相关概念视频
Cancer Vaccines
340
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
340
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
